Neuroglee Therapeutics

Neuroglee is a healthcare startup that operates in the digital health sector, specifically focusing on cognitive care. The company has developed a platform that measures cognitive functioning and well-being of patients throughout their care journey. The platform is designed to serve patients with cognitive impairments, such as those diagnosed with mild cognitive impairment (MCI), and their families.

Neuroglee's business model revolves around providing personalized care plans to help patients form healthy habits and develop practical skills to protect brain health and maintain independence. The company's clinical team provides continuous support, recommends personalized changes to the patient's program, and identifies health concerns early. This integrated approach bridges the gap between the patient's local healthcare team and their home, ensuring optimal care.

The company's digital solutions connect patients and families throughout the care journey with support communities, resources, and exercises to manage the patient's condition. The goal is to slow neurocognitive decline and promote independence. For instance, a patient like Barbara, diagnosed with MCI, would regularly participate in Neuroglee's software-based cognitive training program. The company monitors her cognitive performance, reports improvements to her care team, and recommends educational material to help her stay on track.

Neuroglee generates revenue by partnering with healthcare providers and institutions, like the Mayo Clinic, to digitize and integrate their cognitive care programs into Neuroglee's platform. This allows healthcare providers to offer their patients a comprehensive, digital cognitive care solution.

Keywords: Cognitive Care, Digital Health, Personalized Care Plans, Mild Cognitive Impairment, Continuous Support, Cognitive Performance Monitoring, Software-Based Cognitive Training, Healthcare Partnerships, Digital Cognitive Care Solution, Neurocognitive Decline.